Skip to main content
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: J Endocrinol Diabetes Obes. 2014 Oct;2(4):1057.

Table 3.

Incidence of ≥ 0.5 HbA1c decrease from baseline after one, three and six months of treatment, EE population.

D-tagatose 2.5g D-tagatose 5.0g D-tagatose 7.5g
Treatment
Duration
N = 31
n (%)
N = 29
n (%)
N = 27
n (%)
One Month 6 (19.35%) 7 (24.14%) 2 (7.41%)
Three Months 9 (29.03%) 8 (27.59%) 2 (7.41%)
Six Months 7 (22.58%) 6 (20.69%) 9 (33.33%)

N = denominator for all percentages